AMGEN Inc (NASDAQ: AMGN)’s stock price has dropped by -1.82 in relation to previous closing price of 275.84. Nevertheless, the company has seen a loss of -4.56% in its stock price over the last five trading days. globenewswire.com reported 2025-05-08 that Claremont, CA, May 08, 2025 (GLOBE NEWSWIRE) — During the Keck Graduate Institute commencement ceremony on May 17, 2025, Robert A. Bradway will receive an honorary Doctor of Philosophy in Applied Life Sciences degree in recognition of his significant leadership contributions to the biotechnology field.
Is It Worth Investing in AMGEN Inc (NASDAQ: AMGN) Right Now?
AMGEN Inc (NASDAQ: AMGN) has a higher price-to-earnings ratio of 24.72x compared to its average ratio, The 36-month beta value for AMGN is at 0.51. Analysts have varying views on the stock, with 9 analysts rating it as a “buy,” 6 rating it as “overweight,” 15 as “hold,” and 2 as “sell.”
The public float for AMGN is 536.40M, and currently, shorts hold a 2.71% of that float. The average trading volume for AMGN on May 08, 2025 was 3.08M shares.
AMGN’s Market Performance
The stock of AMGEN Inc (AMGN) has seen a -4.56% decrease in the past week, with a -3.36% drop in the past month, and a -9.05% fall in the past quarter. The volatility ratio for the week is 3.15%, and the volatility levels for the past 30 days are at 3.55% for AMGN. The simple moving average for the past 20 days is -3.82% for AMGN’s stock, with a -10.48% simple moving average for the past 200 days.
Analysts’ Opinion of AMGN
Many brokerage firms have already submitted their reports for AMGN stocks, with Cantor Fitzgerald repeating the rating for AMGN by listing it as a “Neutral.” The predicted price for AMGN in the upcoming period, according to Cantor Fitzgerald is $305 based on the research report published on April 22, 2025 of the current year 2025.
BofA Securities, on the other hand, stated in their research note that they expect to see AMGN reach a price target of $256. The rating they have provided for AMGN stocks is “Underperform” according to the report published on December 10th, 2024.
AMGN Trading at -9.27% from the 50-Day Moving Average
After a stumble in the market that brought AMGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.92% of loss for the given period.
Volatility was left at 3.55%, however, over the last 30 days, the volatility rate increased by 3.15%, as shares sank -7.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.00% lower at present.
During the last 5 trading sessions, AMGN fell by -4.99%, which changed the moving average for the period of 200-days by -19.75% in comparison to the 20-day moving average, which settled at $281.54. In addition, AMGEN Inc saw 3.91% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AMGN starting from Busch Matthew C., who sale 1,000 shares at the price of $279.69 back on May 02 ’25. After this action, Busch Matthew C. now owns 4,034 shares of AMGEN Inc, valued at $279,690 using the latest closing price.
Busch Matthew C., the Officer of AMGEN Inc, proposed sale 1,000 shares at $281.44 during a trade that took place back on May 02 ’25, which means that Busch Matthew C. is holding shares at $281,440 based on the most recent closing price.
Stock Fundamentals for AMGN
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.63 for the gross margin
The net margin for AMGEN Inc stands at 0.17. The total capital return value is set at 0.11. Equity return is now at value 105.67, with 6.51 for asset returns.
Based on AMGEN Inc (AMGN), the company’s capital structure generated 0.9 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 9.24. The interest coverage ratio of the stock is 3.19.
Currently, EBITDA for the company is 13.36 billion with net debt to EBITDA at 3.92. When we switch over and look at the enterprise to sales, we see a ratio of 5.72. The receivables turnover for the company is 4.2for trailing twelve months and the total asset turnover is 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.17.
Conclusion
In conclusion, AMGEN Inc (AMGN) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
